Wei J, Chang C Y, Lee F Y, Lai W Y
Division of Cardiovascular Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
Ann Thorac Surg. 1993 Feb;55(2):482-5. doi: 10.1016/0003-4975(93)91023-g.
Moderate to severe functional tricuspid regurgitation was found in 26% of cardiac surgical patients with mitral or aortic valvular disease at Tri-Service General Hospital in Taiwan. Almost all patients were able to receive de Vega's annuloplasties. After a mean follow-up period of 20 months, none of the 63 patients had moderate or severe tricuspid regurgitation. There was no heart block or right atrial thrombosis; the single late death was not related to the heart disease. De Vega's tricuspid annuloplasty is considered to be a safe, effective, and durable procedure in the treatment of functional tricuspid regurgitation. Compared with tricuspid valve replacement and other types of annuloplasty, the de Vega is the first choice here.
台湾三军总医院的研究发现，在患有二尖瓣或主动脉瓣疾病的心脏外科手术患者中，26%存在中重度功能性三尖瓣反流。几乎所有患者都能够接受德维加瓣环成形术。平均随访20个月后，63例患者中无一例出现中重度三尖瓣反流。无心脏传导阻滞或右心房血栓形成；唯一的晚期死亡与心脏病无关。德维加三尖瓣环成形术被认为是治疗功能性三尖瓣反流的一种安全、有效且持久的手术方法。与三尖瓣置换术和其他类型的瓣环成形术相比，德维加瓣环成形术在此处是首选。
